HSPB6 and amyotrophic lateral sclerosis: Of note, HSPB6 immunoreactivity has been described specifically in astrocytes surrounding areas of tissue damage in the lateral tracts of ALS patients, while no differences in HSPB6 staining were observed in neuronal cells of the spinal cord between patients and healthy subjects (Gorter et al., 2019).